Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Dec 08, 24
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, providing a sustained and effective solution for managing intraocular pressure (IOP). Differing from traditional eye drops that require daily administration, iDose® TR is a small, implantable device crafted to provide a controlled release of medication directly into the eye over an longer period. This innovative approach reduces the burden of constant dosing, dramatically boosting patient adherence and overall treatment results.

At Eye Center South, we are excited to provide iDose® TR as part of our comprehensive glaucoma care. The device is implanted during a minimally invasive procedure, focused on your comfort and ease. Once in place, it provides a steady dose of the prescribed medication, helping to maintain stable IOP levels and protect your vision. Patients who have difficulty managing the challenges of daily eye drop regimens can find relief from this next-generation treatment.



Visit for more info At Eye Center South